 |
January 27, 2026 |
|
Last week marked one year since the US president took office and began systematically dismantling global health and equity. Below is a roundup of essential conversations and resources summarizing the past 365 days and what’s at stake as we move forward.
|
|
|
 |
READ: One Year Later: Global Health Chaos and Disruption
|
|
|
|
|
|
|
 |
WATCH: The People’s Research Agenda
Last week, hundreds joined AVAC for a conversation about The People’s Research Agenda for Speed, Scale and Equity, with Jeanne Marrazzo, former NIAID Director, CEO of the Infectious Diseases Society of America (IDSA), and AVAC Board member. Watch the recording to hear what it will take to deliver science that meets the moment and how advocates can use the People’s Research Agenda, which offers a people-led framework that tracks the science, highlights where investments align with community priorities and identifies critical gaps to ensure the prevention pipeline meets the needs of diverse populations in a reimagined HIV response.
|
|
|
|
|
|
|
 |
LISTEN: One Year After Trump: The Day HIV Funding Changed Forever — and What Came Next
One year ago, Donald Trump was inaugurated as president of the United States and, overnight, US policies on HIV funding for countries like South Africa changed. Bhekisisa’s Mia Malan speaks with AVAC Executive Director Mitchell Warren to find out how international aid has changed.
|
|
|
|
|
|
|
 |
READ: Fighting for Billions: The legal battle to keep US foreign aid alive
Devex’s in-depth retrospective chronicles how legal action became a critical line of defense against the dismantling of lifesaving programs by the US administration — including the ongoing cases by AVAC, the Global Health Council and partners challenging the foreign aid freeze. The piece highlights where we are with the case and why the outcome still matters.
|
|
|
|
|
|
|
READ: Expansion of the Global Gag Rule
Late on Friday, the US Administration dangerously expanded the Global Gag Rule, which further restricts the ability of organizations to engage in advocacy, education programs, discrimination protections, and legal reform, anywhere in the world, in any program, with anyone’s funding.
|
|
|
|
|
| DOWNLOAD: The Latest Infographics from AVAC |
| |
Check out three essential infographics on the HIV vaccine clinical trials pipeline, PrEP products currently available and in late-stage clinical trials and lenacapavir regulatory approvals—to visualize where the field is today and what lies ahead.
|
|
|
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences
|
Unsubscribe
|
|
|